Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole (44545)

Experimental Biology and Medicine

Volumn 224, Issue 4, 2000, Pages 302-308

  Gouillon, Z Q ^a   Lucas, D ^b   Li, J ^a   Hagbjork, A L ^c   French, B A ^a   Fu, P ^a   Fang, C ^c   Ingelman Sundberg, M ^c   Donohue Jr , T M ^d   French, S W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; APOPROTEIN; CHLORZOXAZONE; CLOMETHIAZOLE; CYTOCHROME P450 INHIBITOR; DIMETHYLNITROSAMINE DEMETHYLASE; PROTEASOME;

ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HYDROXYLATION; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; TUBE FEEDING;

ANIMALS; APOENZYMES; BODY WEIGHT; CHLORMETHIAZOLE; CHLORZOXAZONE; CHYMOTRYPSIN; CYSTEINE ENDOPEPTIDASES; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; ETHANOL; HYDROXYLATION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MULTIENZYME COMPLEXES; ORGAN SIZE; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRYPSIN;

ANIMALIA;

EID: 0033872080     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1373.2000.22435.x     Document Type: Article

References (19)

1. Gebhardt AC, Lucas D, Menez J-F, Seitz HK. Chlormethiazole inhibition of cytochrome P4502E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 26:957-996, 1997.
2. Morimoto M, Hagbjork AL, Wan YJY, Fu PC, Clot P, Albano E, Ingelman-Sundberg M, French SW. Modulation of experimental alcohol-induced liver disease by cytochrome P4502E1 inhibitors. Hepatology 21:1610-1617, 1995.
3. Hu Y, Mishin V, Johansson T, Von Bahr C, Cross A, Ronis MJJ, Badger TM, Ingelman-Sundberg M. Chlormethiazole as an efficient inhibitor of cytochrome P4502E1 expression in rat liver. J Pharmacol Exp Ther 269:1286-1291, 1994.
4. Simi A, Ingelman-Sundberg M. Post-translational inhibition of cytochrome P4502E1 expression by chlormethiazole in Fao hepatoma cells. J Pharmacol Exp Ther 289:847-852, 1999.
5. French SW, Zhang-Gouillon ZQ, Ingelman-Sundberg M. Chlormethiazole ameliorated liver pathology induced by ethanol feeding. Hepatology 26:254A, 1997.
6. Donohue TM, Zetterman RR, Lybarger DL, McVicker DL, French SW. Amelioration of ethanol-induced proteasome inactivation by chlormethiazole. (abstract) Alcoholism Clin Exp Res 23:115A, 1999.
7. Lytton SD, Helander A, Zhang-Gouillon Z, Stokkelaud K, Bardone R, Arico S, Albano E, French SW, Ingelman-Sundberg M. Autoantibodies against cytochromes P4502E1 and P4503A in alcoholics. Mol Pharmacol 55:223-233, 1999.
8. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, pp1-128, 1996.
9. Tsukamoto H, French SW, Benson N, Delgado G, Rao GA, Larkin EC, Largenan C. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low-fat diet. Hepatology 5:224-232, 1985.
10. Morimoto M, Reitz RC, Morin RJ, Nguyen K, Ingelman-Sundberg M, French SW. CYP2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high-fat diet. J Nutr 125:2953-2964, 1995.
11. Chen L, Yang CS. Effects of cytochrome P4502E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats. Life Sci 58:1575-1585, 1996.
12. Lucas D, Menez J-F, Berthou F. Chlorzoxazone: An in vitro and in vivo substrate probe for liver CYP2E1. Methods Enzymol 272:115-123, 1996.
13. Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450 (P450IIE1). Biochem Pharmacol 38:1313-1319, 1989.
14. Donohue TM, Zetterman RK, Zhang-Gouillon Z-Q, French SW. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Hepatology 28:486-491, 1998.
15. Korsmeyer KK, Davoll S, Figueíredo-Pereira ME, Correia MA. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome? Arch Biochem Biophys 365:31-44, 1999.
16. Banerjee A, Kocarek TA, Novak RF. Identification of a ubiquitination-target/substrate-interaction domain of cytochrome P450 (CYP) 2EI. Drug Metab Dispos 28:118-124, 2000.
17. Fang C, Lindros KO, Badger TM, Ronis MJ, Ingelman-Sundberg M. Zonated expression of cytokines in rat liver: Effect of chronic ethanol and the cytochrome P4502E1 inhibitor, chlormethiazole. Hepatology 27:1304-1310, 1998.
18. Albano E, French S, Ingelman-Sundberg M. Cytochrome P4502E1, hydroxyethyl free radicals, and immune reactions associated with alcoholic liver disease. Alcoholism Clin Exp Res 22:740-742, 1998.
19. Fataccioli V, Andraud E, Gentil M, French SW, Rouach H. Effects of chronic ethanol administration on rat liver proteasome activities: Relationship with oxidative stress. Hepatology 29:14-20, 1999.